We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$1.25T
AUM Growth
-$1.02T
Cap. Flow
-$1.16T
Cap. Flow %
-93.16%
Top 10 Hldgs %
19.22%
Holding
8,154
New
333
Increased
458
Reduced
6,745
Closed
332

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$50.9B
2
AAPL icon
Apple
AAPL
+$38.9B
3
AMZN icon
Amazon
AMZN
+$26B
4
NVDA icon
NVIDIA
NVDA
+$23.3B
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$17B

Sector Composition

Rank Sector Weight
1 Technology 21.37%
2 Financials 10.81%
3 Healthcare 9.76%
4 Consumer Discretionary 9.08%
5 Industrials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGII icon
3476
Digi International
DGII
$3.1B
$8.12M ﹤0.01%
254,309
-338,047
-57% -$9.44M
JPEM icon
3477
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
$395M
$8.11M ﹤0.01%
151,785
-163,597
-52% -$8.65M
MODN
3478
DELISTED
MODEL N, INC.
MODN
$8.1M ﹤0.01%
284,449
-937,499
-77% -$24.7M
NGD
3479
DELISTED
New Gold Inc
NGD
$8.03M ﹤0.01%
4,724,477
-4,359,079
-48% -$5.95M
IVOG icon
3480
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.7B
$8.03M ﹤0.01%
70,785
-57,731
-45% -$5.97M
PSP icon
3481
Invesco Global Listed Private Equity ETF
PSP
$246M
$8.01M ﹤0.01%
121,425
-90,259
-43% -$5.67M
MAPS
3482
DELISTED
WM TECHNOLOGY INC A
MAPS
$7.99M ﹤0.01%
6,010,631
-5,970,685
-50% -$5.53M
CECO icon
3483
Ceco Environmental
CECO
$4.14B
$7.95M ﹤0.01%
345,521
-391,747
-53% -$8.07M
TPC
3484
Tutor Perini Cor
TPC
$5.21B
$7.95M ﹤0.01%
549,981
-496,891
-47% -$5.07M
ADVM
3485
DELISTED
Adverum Biotechnologies
ADVM
$7.95M ﹤0.01%
562,035
-468,044
-45% -$7.12M
GGB icon
3486
Gerdau
GGB
$9.7B
$7.94M ﹤0.01%
2,156,004
-1,997,777
-48% -$7.23M
DFUS
3487
Dimensional US Equity ETF
DFUS
$21.6B
$7.94M ﹤0.01%
139,308
-127,820
-48% -$6.92M
RYTM icon
3488
Rhythm Pharmaceuticals
RYTM
$7.96B
$7.92M ﹤0.01%
182,870
-280,442
-61% -$12.3M
WW
3489
DELISTED
WW International
WW
$7.91M ﹤0.01%
4,275,256
-9,236,828
-68% -$36.8M
RYZ
3490
Ryerson Holding Corp
RYZ
$1.46B
$7.9M ﹤0.01%
235,853
-385,189
-62% -$12.6M
QURE icon
3491
uniQure
QURE
$3.22B
$7.89M ﹤0.01%
1,518,228
-2,001,408
-57% -$11.5M
XPH icon
3492
State Street SPDR S&P Pharmaceuticals ETF
XPH
$508M
$7.89M ﹤0.01%
183,035
-598,921
-77% -$25.8M
FAB icon
3493
First Trust Multi Cap Value AlphaDEX Fund
FAB
$171M
$7.89M ﹤0.01%
95,464
-107,978
-53% -$8.39M
IMAX icon
3494
IMAX
IMAX
$2.66B
$7.88M ﹤0.01%
487,596
-331,176
-40% -$5.03M
FBRT
3495
Franklin BSP Realty Trust
FBRT
$657M
$7.87M ﹤0.01%
588,798
-666,058
-53% -$8.69M
PETQ
3496
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$7.86M ﹤0.01%
429,718
-420,596
-49% -$7.49M
IAS
3497
DELISTED
Integral Ad Science
IAS
$7.85M ﹤0.01%
787,370
-2,371,870
-75% -$31.7M
TMP icon
3498
Tompkins Financial
TMP
$1.42B
$7.84M ﹤0.01%
155,933
-168,049
-52% -$8.53M
CAAP icon
3499
Corporacion America
CAAP
$4.09B
$7.83M ﹤0.01%
466,087
+51,741
+12% +$802K
VSEC icon
3500
VSE Corp
VSEC
$6.12B
$7.81M ﹤0.01%
97,617
-110,255
-53% -$7.53M

Similar funds

Morgan Stanley's Q1 2024 Portfolio in Review

As of Q1 2024, Morgan Stanley held 8,154 positions worth $1.25T, down 45% from $2.27T the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Morgan Stanley withdrew a net $1.16T in Q1 2024, closing 332 positions and reducing 6,745 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $725M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Morgan Stanley opened a new position in Grayscale Bitcoin Trust worth $270M.

  • Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
  • Morgan Stanley added most to Altria Group in Q1 2024, an estimated $428M increase.
  • Morgan Stanley's biggest Q1 2024 reduction was Microsoft, cutting an estimated $50.9B.
  • Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $725M.
  • Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
  • Morgan Stanley opened 333 new positions and closed 332 in Q1 2024.
  • Morgan Stanley's portfolio value fell 45% quarter-over-quarter to $1.25T.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.